Literature DB >> 4105661

Renal and intrarenal blood-flow in cirrhosis of the liver.

M C Kew, P W Brunt, R R Varma, K J Hourigan, H S Williams, S Sherlock.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1971        PMID： 4105661     DOI： 10.1016/s0140-6736(71)90435-1

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  31 in total

1.  Eicosanoid excretion in hepatic cirrhosis. Predominance of 20-HETE.

Authors:  D Sacerdoti; M Balazy; P Angeli; A Gatta; J C McGiff
Journal:  J Clin Invest       Date:  1997-09-01       Impact factor: 14.808

2.  Effect of portal-systemic anastomosis on renal haemodynamics in cirrhosis.

Authors:  H Ring-Larsen; B Hesse; B Stigsby
Journal:  Gut       Date:  1976-11       Impact factor: 23.059

3.  Functional renal failure (FRF) in cirrhosis of the liver and liver carcinoma.

Authors:  P Vesin; H Traverso
Journal:  Postgrad Med J       Date:  1975-08       Impact factor: 2.401

4.  Reduction in renal blood flow following acute increase in the portal pressure: evidence for the existence of a hepatorenal reflex in man?

Authors:  R Jalan; E H Forrest; D N Redhead; J F Dillon; P C Hayes
Journal:  Gut       Date:  1997-05       Impact factor: 23.059

5.  Renal tissue mast cells in liver diseases.

Authors:  A Yoshimura; W Mori
Journal:  Int Urol Nephrol       Date:  1991       Impact factor: 2.370

6.  Effect of meal induced splanchnic arterial vasodilatation on renal arterial haemodynamics in normal subjects and patients with cirrhosis.

Authors:  T Iwao; K Oho; R Nakano; M Yamawaki; T Sakai; M Sato; Y Miyamoto; A Toyonaga; K Tanikawa
Journal:  Gut       Date:  1998-12       Impact factor: 23.059

7.  The hepatorenal syndrome.

Authors:  M Pinzani; R D Zipser
Journal:  Intensive Care Med       Date:  1987       Impact factor: 17.440

Review 8.  Renal changes in cirrhosis.

Authors:  M Kew
Journal:  Gut       Date:  1972-09       Impact factor: 23.059

9.  Effectiveness of ibopamine in the management of ascitic liver cirrhosis--a controlled study v placebo and frusemide.

Authors:  G F Melloni; G M Minoja; R Melloni; E Piatto; E Scarazzati; R Bauer; P Ghirardi
Journal:  Br J Clin Pharmacol       Date:  1981-12       Impact factor: 4.335

10.  [Hepato-renal syndrome (author's transl)].

Authors:  J Kipnowski; R Düsing; H J Kramer
Journal:  Klin Wochenschr       Date:  1981-05-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.